Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global comprehensive metabolic panel testing market 3600 synopsis, 2018 – 2032
2.2 Regional trends
2.3 Test type trends
2.4 Disease indication trends
2.5 End-use trends
Chapter 3 Comprehensive Metabolic Panel Testing Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing prevalence of diabetes
3.5.1.2 Technological advancements in comprehensive metabolic panel testing
3.5.1.3 Growing awareness regarding early diagnosis and treatment of diseases
3.5.1.4 Growing inclination towards usage of point of care devices
3.5.2 Industry pitfalls & challenges
3.5.2.1 Lack of reimbursement scenario
3.5.2.2 Stringent regulatory scenario
3.6 Growth potential analysis
3.6.1 By test type
3.6.2 By disease indication
3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Abbott Laboratories
4.1.2 Quest Diagnostics
4.1.3 Laboratory Corporation of America Holdings Limited
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Comprehensive Metabolic Panel Testing Market Size and Forecast, By Test Type, 2018-2032 (USD Million)
5.1 Key trends, by test type
5.2 Glucose
5.3 Calcium
5.4 Electrolytes
5.4.1 Sodium
5.4.2 Potassium
5.4.3 Other electrolytes
5.5 Kidney function tests
5.5.1 Blood urea nitrogen (BUN)
5.5.2 Creatinine
5.6 Liver function tests
5.6.1 Albumin
5.6.2 Bilirubin
5.6.3 Alkaline phosphatase
5.6.4 Aspartate aminotransferase (AST)
5.6.5 Alanine aminotransferase (ALT)
5.7 Proteins
Chapter 6 Comprehensive Metabolic Panel Testing Market Size and Forecast, By Disease Indication, 2018-2032 (USD Million)
6.1 Key trends, by disease indication
6.2 Kidney diseases
6.3 Liver diseases
6.4 Diabetes
6.5 Other disease indications
Chapter 7 Comprehensive Metabolic Panel Testing Market Size and Forecast, By End-use, 2018-2032 (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Point of care centers
7.5 Other end-users
Chapter 8 Comprehensive Metabolic Panel Testing Market Size and Forecast, By Region, 2018-2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Quest Diagnostics
9.3 Laboratory Corporation of America Holdings Limited
9.4 Sonic Healthcare
9.5 Unipath
9.6 SYNLAB International GmbH
9.7 ARUP Laboratories
9.8 Genoptix Inc.
9.9 Nova Medical
9.10 Charles River Laboratories Inc.
9.11 Scion Lab Services LLC
9.12 Walk-In Lab, LLC
9.13 CENTOGENE N.V.
9.14 Abaxis
